<DOC>
	<DOC>NCT02696031</DOC>
	<brief_summary>To demonstrate the clinical efficacy, safety and tolerability of secukinumab compared to placebo in patients with non-radiographic axial spondyloarthritis at Week 16 as well as week 52 and long term efficacy and safety up to Week 104.</brief_summary>
	<brief_title>Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis</brief_title>
	<detailed_description />
	<mesh_term>Spondylarthritis</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>Male or nonpregnant, nonnursing female patients at least 18 years of age Diagnosis of axial spondyloarthritis according to Ankylosing SpondyloArthritis International Society (ASAS) axial spondyloarthritis criteria objective signs of inflammation (magnetic resonance imaging (MRI) or abnormal Creactive protein) active axial spondyloarthritis as assessed by total Bath Ankylosing Spondylitis Disease Activity Index &gt;=4 cm Spinal pain as measured by Bath Ankylosing Spondylitis Disease Activity Index question #2 ≥ 4 cm (010 cm) at baseline Total back pain as measured by Visual Analogue scale ≥ 40 mm (0100 mm) at baseline Patients should have been on at least 2 different nonsteroidal antiinflammatory drugs with an inadequate response Patients who have been on a TNFα inhibitor (not more than one) must have experienced an inadequate response Patients with radiographic evidence for sacroiliitis, grade ≥ 2 bilaterally or grade ≥ 3 unilaterally Inability or unwillingness to undergo MRI Chest Xray or MRI with evidence of ongoing infectious or malignant process Patients taking high potency opioid analgesics Previous exposure to secukinumab or any other biologic drug directly targeting interleukin17 (IL17) or IL17 receptor Pregnant or nursing (lactating) women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>non-radiographic spondyloarthritis</keyword>
	<keyword>axial spondyloarthritis</keyword>
</DOC>